BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21526198)

  • 1. Differential expressions of adhesive molecules and proteases define mechanisms of ovarian tumor cell matrix penetration/invasion.
    Kwon Y; Cukierman E; Godwin AK
    PLoS One; 2011 Apr; 6(4):e18872. PubMed ID: 21526198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells.
    Lee HO; Mullins SR; Franco-Barraza J; Valianou M; Cukierman E; Cheng JD
    BMC Cancer; 2011 Jun; 11():245. PubMed ID: 21668992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression.
    Kokenyesi R; Murray KP; Benshushan A; Huntley ED; Kao MS
    Gynecol Oncol; 2003 Apr; 89(1):60-72. PubMed ID: 12694655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion.
    Jeong KJ; Park SY; Cho KH; Sohn JS; Lee J; Kim YK; Kang J; Park CG; Han JW; Lee HY
    Oncogene; 2012 Sep; 31(39):4279-89. PubMed ID: 22249252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis.
    Klymenko Y; Kim O; Loughran E; Yang J; Lombard R; Alber M; Stack MS
    Oncogene; 2017 Oct; 36(42):5840-5851. PubMed ID: 28628116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contact guidance mediated three-dimensional cell migration is regulated by Rho/ROCK-dependent matrix reorganization.
    Provenzano PP; Inman DR; Eliceiri KW; Trier SM; Keely PJ
    Biophys J; 2008 Dec; 95(11):5374-84. PubMed ID: 18775961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers.
    Burleson KM; Hansen LK; Skubitz AP
    Clin Exp Metastasis; 2004; 21(8):685-97. PubMed ID: 16035613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrillar type I collagen matrices enhance metastasis/invasion of ovarian epithelial cancer via β1 integrin and PTEN signals.
    Shen Y; Shen R; Ge L; Zhu Q; Li F
    Int J Gynecol Cancer; 2012 Oct; 22(8):1316-24. PubMed ID: 23013730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromelysin-1/matrix metalloproteinase-3 (MMP-3) expression accounts for invasive properties of human astrocytoma cell lines.
    Mercapide J; Lopez De Cicco R; Castresana JS; Klein-Szanto AJ
    Int J Cancer; 2003 Sep; 106(5):676-82. PubMed ID: 12866026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer Cells Invade Confined Microchannels via a Self-Directed Mesenchymal-to-Amoeboid Transition.
    Holle AW; Govindan Kutty Devi N; Clar K; Fan A; Saif T; Kemkemer R; Spatz JP
    Nano Lett; 2019 Apr; 19(4):2280-2290. PubMed ID: 30775927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-binding epidermal growth factor-like growth factor promotes transcoelomic metastasis in ovarian cancer through epithelial-mesenchymal transition.
    Yagi H; Yotsumoto F; Miyamoto S
    Mol Cancer Ther; 2008 Oct; 7(10):3441-51. PubMed ID: 18852147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformation of epithelial ovarian cancer stemlike cells into mesenchymal lineage via EMT results in cellular heterogeneity and supports tumor engraftment.
    Jiang H; Lin X; Liu Y; Gong W; Ma X; Yu Y; Xie Y; Sun X; Feng Y; Janzen V; Chen T
    Mol Med; 2012 Oct; 18(1):1197-208. PubMed ID: 22801793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staged stromal extracellular 3D matrices differentially regulate breast cancer cell responses through PI3K and beta1-integrins.
    Castelló-Cros R; Khan DR; Simons J; Valianou M; Cukierman E
    BMC Cancer; 2009 Mar; 9():94. PubMed ID: 19323811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host matrix modulation by tumor exosomes promotes motility and invasiveness.
    Mu W; Rana S; Zöller M
    Neoplasia; 2013 Aug; 15(8):875-87. PubMed ID: 23908589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra-cellular matrices on adhesion and invasion of ovarian cancer cells to the omentum.
    Kenny HA; Krausz T; Yamada SD; Lengyel E
    Int J Cancer; 2007 Oct; 121(7):1463-72. PubMed ID: 17546601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.
    Rosanò L; Spinella F; Di Castro V; Nicotra MR; Dedhar S; de Herreros AG; Natali PG; Bagnato A
    Cancer Res; 2005 Dec; 65(24):11649-57. PubMed ID: 16357176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis.
    Wolf K; Mazo I; Leung H; Engelke K; von Andrian UH; Deryugina EI; Strongin AY; Bröcker EB; Friedl P
    J Cell Biol; 2003 Jan; 160(2):267-77. PubMed ID: 12527751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses.
    Härmä V; Virtanen J; Mäkelä R; Happonen A; Mpindi JP; Knuuttila M; Kohonen P; Lötjönen J; Kallioniemi O; Nees M
    PLoS One; 2010 May; 5(5):e10431. PubMed ID: 20454659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of gelatinases linked to extracellular matrix invasion in ovarian adenocarcinoma: purification of matrix metalloproteinase 2.
    Young TN; Rodriguez GC; Rinehart AR; Bast RC; Pizzo SV; Stack MS
    Gynecol Oncol; 1996 Jul; 62(1):89-99. PubMed ID: 8690299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer.
    Ahmed N; Abubaker K; Findlay J; Quinn M
    Curr Cancer Drug Targets; 2010 May; 10(3):268-78. PubMed ID: 20370691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.